Resources & Information

Reading Room

The reading room includes articles and videos of potential interest to consumers and medical professionals. The opinions expressed do not necessarily reflect the views of the NC Medical Board, its members and staff.

Flu science points to another culprit when vaccines fail — us

January 24, 2019
If you’ve ever gotten a flu shot — and then, later that season, gotten the flu — you were more than likely, and rightly, miffed. Your doctor might have explained that the problem was possibly that the influenza vaccine wasn’t well matched that year to the strains people coughed and sneezed in your direction.

Read More…

Scientists are teaching the body to accept new organs

The New York Times
January 22, 2019
Patients receiving new kidneys and livers must take damaging anti-rejection drugs for the rest of their lives. Now researchers hope to train the immune system instead of just tamping it down.

Read More…

A ‘digital pill’ for cancer patients is rolled out for the first time, in hopes of improving outcomes

January 17, 2019
A Silicon Valley company on Thursday announced what it described as the first “digital pill” program of its kind, one in which the chemotherapy pills taken by cancer patients are packaged with a sensor that can alert a physician, pharmacist, or caregiver after it has been swallowed.

Read More…

The work-from-home doctor will see you now

San Francisco Chronicle
December 1, 2018
It’s been about two years since Dr. Ian Tong has seen a patient — in person, that is. But Tong treats patients all the time through a secure video-chatting application on his laptop, from the San Francisco headquarters of Doctor On Demand, the telemedicine company he helps lead as chief medical officer. The same goes for the roughly 150 physicians employed by Doctor On Demand who primarily work from home from all over the United States.

Read More…

What will 2019 bring for science and medicine?

December 31, 3018
It has been a tumultuous year for science and medicine, and also for the business and politics of both. And with CRISPR babies still in the headlines, Donald Trump still in the White House, and the Dow down again, 2019 is shaping up to be just as turbulent.

Read More…